These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9549720)

  • 21. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
    Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
    J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].
    Korovaĭtseva GI; Shcherbatykh TV; Selezneva NV; Gavrilova SI; Golimbet VE; Voskresenskaia NI; Rogaev EI
    Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary.
    Kovács KA; Pámer Z; Kovács A; Fekete S; Miseta A; Kovács B; Kovács GL
    Ideggyogy Sz; 2007 Mar; 60(3-4):169-72. PubMed ID: 17451062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults.
    Mauricio M; O'Hara R; Yesavage JA; Friedman L; Kraemer HC; Van De Water M; Murphy GM
    Am J Geriatr Psychiatry; 2000; 8(3):196-200. PubMed ID: 10910416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum apolipoprotein A I, B100 and E levels and apolipoprotein E polymorphism in patients with Alzheimer's disease and multiple infarction dementia in Chinese population].
    Fan P; Liu Y; Zhang Z; Liu B; Ge W; Ye S; Cheng Y; Chen J
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):389-91. PubMed ID: 12536572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol and APOE genotype interact to influence Alzheimer disease progression.
    Evans RM; Hui S; Perkins A; Lahiri DK; Poirier J; Farlow MR
    Neurology; 2004 May; 62(10):1869-71. PubMed ID: 15159498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease.
    Lesser G; Kandiah K; Libow LS; Likourezos A; Breuer B; Marin D; Mohs R; Haroutunian V; Neufeld R
    Dement Geriatr Cogn Disord; 2001; 12(2):138-45. PubMed ID: 11173887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
    Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
    Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives.
    Farrer LA; Cupples LA; van Duijn CM; Kurz A; Zimmer R; Müller U; Green RC; Clarke V; Shoffner J; Wallace DC
    Ann Neurol; 1995 Nov; 38(5):797-808. PubMed ID: 7486872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application.
    Lückhoff HK; Kidd M; van Rensburg SJ; van Velden DP; Kotze MJ
    Metab Brain Dis; 2016 Feb; 31(1):213-24. PubMed ID: 26481640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
    Cui T; Zhou X; Jin W; Zheng F; Cao X
    Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the effect of the apolipoprotein E genotype on the lipid profile in Alzheimer's disease.
    Sabbagh MN; Sandhu S; Kolody H; Lahti T; Silverberg NB; Sparks DL
    Curr Alzheimer Res; 2006 Apr; 3(2):157-60. PubMed ID: 16611016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study.
    Kuusisto J; Koivisto K; Mykkänen L; Helkala EL; Vanhanen M; Hänninen T; Kervinen K; Kesäniemi YA; Riekkinen PJ; Laakso M
    BMJ; 1997 Oct; 315(7115):1045-9. PubMed ID: 9366728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E phenotypes and serum lipids in newborns and 3-year-old children: the Cardiovascular Risk in Young Finns Study.
    Lehtimäki T; Porkka K; Viikari J; Ehnholm C; Akerblom HK; Nikkari T
    Pediatrics; 1994 Oct; 94(4 Pt 1):489-93. PubMed ID: 7936857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype.
    Craft S; Asthana S; Schellenberg G; Baker L; Cherrier M; Boyt AA; Martins RN; Raskind M; Peskind E; Plymate S
    Ann N Y Acad Sci; 2000 Apr; 903():222-8. PubMed ID: 10818510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ApoE polymorphism in Polish patients with Alzheimer's disease.
    Lalowski MM; Czyzewski K; Pfeffer A; Barcikowska M; Kwieciński H
    Acta Neurobiol Exp (Wars); 1998; 58(1):65-8. PubMed ID: 9583189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
    Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
    Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
    Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.